We are monitoring the impact of COVID-19 on North America Chlamydia Infection Diagnostics and Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 4955
Share on
Share on

North America Chlamydia Infection Diagnostics and Therapeutics Market Research Report – Segmented By Product Type, End User and Country (United States, Canada and Rest of North America) - Industry Analysis, Size, Share, Growth, Trends and Forecast (2021 to 2026)

Pulished: April, 2021
ID: 4955
Pages: 145

North America Chlamydia Infection Diagnostics & Therapeutics Market Size (2021 to 2026)

The size of the Chlamydia Infection Diagnostics and Therapeutics Market in North America was around USD 0.95 billion in 2021. It is expected to grow at a CAGR of 5.6% to reach USD 1.25 billion by 2026. It captures 40% of the global market.

The rise in the provenance of diseases such as chlamydia infection, sexually transmitted diseases, is leading to a constant increase in demand for the North America chlamydia infection diagnostics therapeutics market. High risk of contamination of chlamydia among younger people is also propelling the growth of the market. In North America, government authorities are taking initial steps to enhance healthcare services and with advanced therapeutic and diagnostic techniques which are contributing to the growth of this market. The novel devices for diagnosing infections are continuously emerging into the market owing to the intensive research, and technological developments are propelling the growth of the Chlamydia infection diagnostics and therapeutics market in North America. The availability of adequate and sensitive diagnostics tests in North America is also fuelling the growth rate of the Chlamydia infection diagnostics and therapeutics market in this region. 

Fear of shame associated with chlamydia diagnosis and therapies among younger people primarily between the age groups amid 16 and 25, due to which they might avoid screening and determination of the disease, and this is the challenging the growth of North America Chlamydia infection diagnosis and therapeutics market. 

A rising account of STDs and steadily increasing patient base are likely to boost the demand for chlamydia infection diagnostics and therapeutics which are expected to offer growth opportunities for the stakeholders in the market during the forecast period. Intensive focus on initiatives from the private and public organizations for developing innovative Chlamydia infection diagnostics and therapeutics owing to immense advancements in medical science and technology in order to meet the continuously rising demand of the medical needs is expected to be creating more growth opportunities for the regional market over the forecast period. 

This research report is segmented & sub-segmented into the following categories:

  • By Product: Diagnostics (Nucleic Acid Amplification Tests (NAATs), Direct Fluorescent Tests and PCR), Therapeutics (Macrolides, Quinolones, Sulfonamides, Tetracycline and Aminopenicillins)
  • By End User: Diagnostics (Hospitals, Specialty Clinics and Diagnostic Centers), Therapeutics (Hospital Pharmacies, Drugstores, Retail Pharmacies and Online Pharmacies
  • By Country: United States, Canada and Rest of North America

Regionally, increasing prevalence of infections among younger people due to biological factors is boosting the number of opportunities for the growth of the Chlamydia infection diagnostics and therapeutics market in North America. Also, easy approval of novel devices for therapeutic procedures is anticipated to create growth opportunities for the chlamydia infection diagnosis and therapeutics market in North America. Increasing expenditure of healthcare and boosting economies of the countries like the U.S, Canada and others in North America are foreseen to create lucrative opportunities for the market players in the region during the projection period.

Key players in the North America Chlamydia Infection Diagnostics & Therapeutics Market include Bio Rad laboratories, Novartis AG, F Hoffmann-La Roche, Abbott Laboratories, Danaher. Other players in the market include bioMerieux, DiaSorin SpA, Siemens AG, Thermo Fisher Scientific, and Becton Dickinson and Company.

1.Introduction                                 

               1.1 Market Definition                    

               1.2 Study Deliverables                  

               1.3 Base Currency, Base Year and Forecast Periods                          

               1.4 General Study Assumptions                 

2. Research Methodology                                          

               2.1 Introduction                             

               2.2 Research Phases                      

                              2.2.1 Secondary Research           

                              2.2.2 Primary Research 

                              2.2.3 Econometric Modelling      

                              2.2.4 Expert Validation  

               2.3 Analysis Design                        

               2.4 Study Timeline                         

3. Overview                                     

               3.1 Executive Summary                

               3.2 Key Inferences                         

               3.3 Epidemology                            

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

               4.1 Market Drivers                         

               4.2 Market Restraints                   

               4.3 Key Challenges                         

               4.4 Current Opportunities in the Market               

5. Market Segmentation                                            

               5.1 Product Type                            

                              5.1.1 Introduction           

                              5.1.2 Diagnostics             

                                             5.1.2.1 Nucleic Acid Amplification Tests (NAATs)

                                             5.1.2.2 Direct Fluorescent Tests

                                             5.1.2.3 PCR

                              5.1.3 Therapeutics          

                                             5.1.3.1 Macrolides

                                             5.1.3.2 Quinolones

                                             5.1.3.3 Sulfonamides

                                             5.1.3.4 Tetracycline

                                             5.1.3.5 Aminopenicillins

                              5.1.4 Y-o-Y Growth Analysis, By Product Type     

                              5.1.5 Market Attractiveness Analysis, By Product Type    

                              5.1.6 Market Share Analysis, By Product Type     

               5.2 End User                     

                              5.2.1 Introduction           

                              5.2.2 Diagnostics             

                                             5.2.2.1 Hospitals

                                             5.2.2.2 Specialty Clinics

                                             5.2.2.3 Diagnostic Centers

                              5.2.3 Therapeutics          

                                             5.2.3.1 Hospital Pharmacies

                                             5.2.3.2 Drugstores

                                             5.2.3.3 Retail Pharmacies

                                             5.2.3.4 Online Pharmacies

                              5.2.4 Y-o-Y Growth Analysis, By End User             

                              5.2.5 Market Attractiveness Analysis, By End User            

                              5.2.6 Market Share Analysis, By End User             

6. Geographical Analysis                                            

               6.1 Introduction                             

                              6.1.1 Regional Trends    

                              6.1.2 Impact Analysis     

                              6.1.3 Y-o-Y Growth Analysis        

                                             6.1.3.1 By Geographical Area

                                             6.1.3.2 By Product Type

                                             6.1.3.3 By End User

                              6.1.4  Market Attractiveness Analysis      

                                             6.1.4.1 By Geographical Area

                                             6.1.4.2 By Product Type

                                             6.1.4.3 By End User

                              6.1.5  Market Share Analysis       

                                             6.1.5.1 By Geographical Area

                                             6.1.5.2 By Product Type

                                             6.1.5.3 By End User

               6.2 United States                           

               6.3 Canada                       

7. Strategic Analysis                                      

               7.1 PESTLE analysis                        

                              7.1.1 Political    

                              7.1.2 Economic 

                              7.1.3 Social        

                              7.1.4 Technological        

                              7.1.5 Legal         

                              7.1.6 Environmental       

               7.2 Porter’s Five analysis                             

                              7.2.1 Bargaining Power of Suppliers         

                              7.2.2 Bargaining Power of Consumers     

                              7.2.3 Threat of New Entrants      

                              7.2.4 Threat of Substitute Products and Services

                              7.2.5 Competitive Rivalry within the Industry      

8. Market Leaders' Analysis                                       

               8.1 Bio Rad laboratories               

                              8.1.1 Overview 

                              8.1.2 Product Analysis   

                              8.1.3 Financial analysis  

                              8.1.4 Recent Developments        

                              8.1.5 SWOT analysis       

                              8.1.6 Analyst View          

               8.2 Novartis AG               

               8.3 F Hoffmann-La Roche                           

               8.4 Abbott Laboratories               

               8.5 Danaher                      

               8.6 bioMerieux                

               8.7 DiaSorin SpA                             

               8.8 Siemens AG               

               8.9 Thermo Fisher Scientific                       

               8.10 Becton Dickinson and Company                     

9. Competitive Landscape                                         

               9.1 Market share analysis                           

               9.2 Merger and Acquisition Analysis                       

               9.3 Agreements, collaborations and Joint Ventures                          

               9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                          

               a) List of Tables                

               b) List of Figures                             

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms product type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2021 to 2026 (USD Billion)
  2. North America Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  3. North America Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  4. North America Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2021 to 2026 (USD Billion)
  5. North America Diagnostics Market, By Region, From 2021 to 2026 (USD Billion)
  6. North America Therapeutics Market, By Region, From 2021 to 2026 (USD Billion)
  7. United States Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2021 to 2026 (USD Billion)
  8. United States Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2021 to 2026 (USD Billion)
  9. Canada Chlamydia Infection Diagnostics and Therapeutics Market, By Product Type, From 2021 to 2026 (USD Billion)
  10. Canada Chlamydia Infection Diagnostics and Therapeutics Market, By End User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample